Amundi’s Outset Medical OM Stock Holding History

Amundi’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,818	Closed	-$398K	–	2055
2023 Q3	$398K	Buy	7,818 +375	+5%	+$88.5K	﹤0.01%	1449
2023 Q2	$2.31M	Sell	7,443 -308	-4%	-$93.9K	﹤0.01%	1134
2023 Q1	$2.04M	Sell	7,751 -36	-0.5%	-$13.2K	﹤0.01%	1145
2022 Q4	$3.1M	Sell	7,787 -459	-6%	-$129K	﹤0.01%	1110
2022 Q3	$2.04M	Buy	8,246 +3,143	+62%	+$842K	﹤0.01%	1145
2022 Q2	$1.24M	Buy	+5,103	New	+$2.2M	﹤0.01%	1135

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Amundi's OM Position: Q4 2023 in Review

Amundi sold out of Outset Medical (OM) in Q4 2023, closing a stake of 7,818 shares — an estimated $398K sold.

Amundi first reported a position in OM in Q2 2022 and held it in 6 quarters. The position peaked at $3.1M in Q4 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Amundi reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Amundi sold 7,818 Outset Medical shares in Q4 2023, an estimated $398K.
Amundi first reported a position in Outset Medical in Q2 2022 and held it in 6 quarters.
Amundi's Outset Medical position peaked at $3.1M in Q4 2022.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.